Clinical use of Haemate® P in inherited von Willebrand's disease: a cohort study on 100 Italian patients | Haematologica
![HAEMATE P 2400 UI/1000 UI 1 VIAL POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION + 1 AMPOLLA DISOLVENTE - Farmacéuticos HAEMATE P 2400 UI/1000 UI 1 VIAL POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION + 1 AMPOLLA DISOLVENTE - Farmacéuticos](https://botplusweb.farmaceuticos.com/Documentos/AEMPS/Fotos/92943/full/56868_materialas.jpg)
HAEMATE P 2400 UI/1000 UI 1 VIAL POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION + 1 AMPOLLA DISOLVENTE - Farmacéuticos
![WO2008151817A1 - Use of vwf stabilized fviii preparations and of vwf preparations without fviii for extravascular administration in the therapy and prophylactic treatment of bleeding disorders - Google Patents WO2008151817A1 - Use of vwf stabilized fviii preparations and of vwf preparations without fviii for extravascular administration in the therapy and prophylactic treatment of bleeding disorders - Google Patents](https://patentimages.storage.googleapis.com/18/16/36/c0799ff84d970c/imgf000031_0001.png)
WO2008151817A1 - Use of vwf stabilized fviii preparations and of vwf preparations without fviii for extravascular administration in the therapy and prophylactic treatment of bleeding disorders - Google Patents
![WO2008151817A1 - Use of vwf stabilized fviii preparations and of vwf preparations without fviii for extravascular administration in the therapy and prophylactic treatment of bleeding disorders - Google Patents WO2008151817A1 - Use of vwf stabilized fviii preparations and of vwf preparations without fviii for extravascular administration in the therapy and prophylactic treatment of bleeding disorders - Google Patents](https://patentimages.storage.googleapis.com/cc/4d/ef/7593f4f8f5cd52/imgf000037_0001.png)
WO2008151817A1 - Use of vwf stabilized fviii preparations and of vwf preparations without fviii for extravascular administration in the therapy and prophylactic treatment of bleeding disorders - Google Patents
Clinical use of Haemate® P in inherited von Willebrand's disease: a cohort study on 100 Italian patients | Haematologica
![PDF) Safety and Efficacy of Continuous Infusion of a Combined Factor VIII – von Willebrand Factor (vWF) Concentrate (Haemate-P™) in Patients with von Willebrand Disease PDF) Safety and Efficacy of Continuous Infusion of a Combined Factor VIII – von Willebrand Factor (vWF) Concentrate (Haemate-P™) in Patients with von Willebrand Disease](https://i1.rgstatic.net/publication/13226652_Safety_and_Efficacy_of_Continuous_Infusion_of_a_Combined_Factor_VIII_-_von_Willebrand_Factor_vWF_Concentrate_Haemate-P_in_Patients_with_von_Willebrand_Disease/links/0a85e53ab8c9a03057000000/largepreview.png)
PDF) Safety and Efficacy of Continuous Infusion of a Combined Factor VIII – von Willebrand Factor (vWF) Concentrate (Haemate-P™) in Patients with von Willebrand Disease
Clinical use of Haemate® P in inherited von Willebrand's disease: a cohort study on 100 Italian patients | Haematologica
![Evaluation of von Willebrand factor concentrates by platelet adhesion to collagen using an in vitro flow assay - Research and Practice in Thrombosis and Haemostasis Evaluation of von Willebrand factor concentrates by platelet adhesion to collagen using an in vitro flow assay - Research and Practice in Thrombosis and Haemostasis](https://www.rpthjournal.org/cms/asset/6065db76-b696-43a6-b1f7-f80280d3d8c0/rth212166-fig-0001-m.jpg)